Usana 4Q profit doubles on lower general costs (Associated Press)
GSK reveals plans to trim workforce at UK research site (Pharmatimes.com)
Sanofi-Aventis Q4 Profit Up on Swine Flu Vaccines (Associated Press)
Blow for Novartis and B-MS as NICE rejects Afinitor, Tasigna and Sprycel (Pharmatimes.com)
China publishes first-ever drug advice for doctors (Pharmatimes.com)
Genzyme, Isis say cholesterol drug met trial goal (Associated Press)
SUBSCRIBE